Breast CancerClinical TopicsNewsOncologyTargeted TherapyWomen's Health

Scientists can silence inflammatory gene responsible for a form of breast cancer

Author(s): By Riley Kleemeier
Share

Scientists have found that they are able to “switch off,” or silence, a gene that is responsible for an aggressive form of breast cancer.

Researchers worked with two known breast cancer genes, Rab27a and TRAF31P2, to test the effects of “switching them off.” When the researchers “switched off” the TRAF31P2 gene, they found that this suppressed the growth of the patients’ tumors and prevented metastasis for up to one year. Furthermore, previously existing tumors shrank until undetectable.

The final takeaway from the study concluded that the TRAF3IP2 gene could be targeted in a novel therapeutic approach.

To read more about this study, please click here.

Source: https://www.nature.com/articles/s41598-020-64781-z.epdf?sharing_token=g5pMd4_e6Nk6moKYt8K719RgN0jAjWel9jnR3ZoTv0NqsC8K8p3YcQkhq3pkVMte2MxGIYJilndbyCeof7SHjPMZP5hYcb2EeflxdT2dIdfwhRxJzVCGaDZq4LiDTtpIlqpA9_XIwKptc-BPRuaFkiV58_Sfnm0joShFtH4mRsQ%3D

Get your free subscription to the Women's Healthcare Newsletter!

Women's Healthcare Newsletter Sidebar

Enter your email to receive our bi-weekly newsletter from the publishers of Women's Healthcare

  • This field is for validation purposes and should be left unchanged.
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Quiz

According to the CDC, approximately how many women will develop breast cancer in their life?
You must be logged in to post a comment.

Poll

Get your free subscription to the Women's Healthcare Newsletter!

Women's Healthcare Newsletter Sidebar

Enter your email to receive our bi-weekly newsletter from the publishers of Women's Healthcare

  • This field is for validation purposes and should be left unchanged.
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.